Protocol No
RHEU-MILTENYI-M-2024-423
Staff Member
David Gazeley
Phase
I
Summary
This project is being done to to find out if the investigational autologous transplantation of CAR-T cells is safe and tolerable to treat severe autoimmune diseases such as SSc and dcSSc and SLE-Non renal and SLE-LN.
Objective
US Zamto-cel Autoimmune Diseases
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov